Laparoscopic partial cystectomy for treatment of adenocarcinoma of the urachus

Milhoua, Paul M.; Knoll, Abraham; Bleustein, Clifford B.; Ghavamian, Reza

doi:10.1016/j.urology.2005.08.044

Cited by 32 publications

(18 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In 2004, Mariano and Tefilli 12 reported their initial experience with LPC for six patients with urothelial carcinoma of the bladder at a mean follow-up of 30 months. Recently, Milhoua et al 13 and Wadhwa et al 14 also reported their experience with LPC in managing urachal adenocarcinoma.…”

Section: Discussionmentioning

confidence: 99%

Robotic Partial Cystectomy for Bladder Cancer: A Single-Institutional Pilot Study

Allaparthi

Rajan

Balaji

2010

Journal of Endourology

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Robotic Partial Cystectomy for Bladder Cancer: A Single-Institutional Pilot Study

Allaparthi

Rajan

Balaji

2010

Journal of Endourology

View full text Add to dashboard Cite

show abstract

“…2 The gold standard of treatment for muscle invasive bladder cancer is radical cystectomy 3,4 but the alternative of partial cystectomy (PC) has gained popularity and has been shown to provide comparable 5-year survival rates to patients treated with radical cystectomy. 1,5 In 2006 Milhoua's team published the successful outcome of a patient with primary malignant UA who underwent a laparoscopic extended PC and en bloc removal of the urachus and umbilicus; this patient remained disease-free at 18 months. 5 In 2010 Allaparthi's team published the successful short-term outcome of a patient with UA who underwent robotic PC (RPC).…”

Section: Introductionmentioning

confidence: 99%

“…1,5 In 2006 Milhoua's team published the successful outcome of a patient with primary malignant UA who underwent a laparoscopic extended PC and en bloc removal of the urachus and umbilicus; this patient remained disease-free at 18 months. 5 In 2010 Allaparthi's team published the successful short-term outcome of a patient with UA who underwent robotic PC (RPC). 6 Here we present the case of a patient with metastatic UA who underwent robotic PC who is alive with no evidence of disease recurrence or metastatic disease at 5 years.…”

Section: Introductionmentioning

confidence: 99%

The role of robotic partial cystectomy in a patient with metastatic primary adenocarcinoma of the bladder

Vasdev

Adshead

2015

Int J Cancer Ther Oncol

View full text Add to dashboard Cite

Case Report AbstractTreatment of urachal adenocarcinoma (UA) of the urinary bladder has typically been with radical cystectomy (RC) but more conservative approaches are gaining popularity. Here we present the case of a female patient with metastatic primary bladder UA who was treated with robotic partial cystectomy (RPC) and adjuvant chemotherapy; she is alive with no evidence of disease recurrence or metastatic disease at 5 years. This case provides some of the longest follow-up after RPC to date thereby demonstrating that RPC is a safe and oncologically viable treatment for selected patients even several years after definitive treatment.Patients undergoing RPC benefit from the reduced morbidity associated with this less radical treatment whilst enjoying similarly successful oncological outcomes to RC.

show abstract

“…The first laparoscopic partial cystectomy (LPC) was described by Nezhat and Nezhat [8] in 1993 for the treatment of bladder endometriosis. Thereafter, some researchers have reported the application of LPC to bladder lesions such as urothelial carcinoma [9] and urachal adenocarcinoma [10,11]. However, it should be emphasized that LPC should not be performed for patients diagnosed with transitional cell carcinoma.…”

Section: Introductionmentioning

confidence: 99%

Extraperitoneal and Transperitoneal Laparoscopic Partial Cystectomy for Benign Non-Urothelial Bladder Tumors: An Initial Experience

Tong

et al. 2014

Urol Int

View full text Add to dashboard Cite

Objective: This study presents our initial experience with extraperitoneal and transperitoneal laparoscopic partial cystectomy (LPC) in the treatment of benign non-urothelial bladder tumors. Methods: Eleven patients with benign non-urothelial bladder tumors underwent extraperitoneal or transperitoneal LPC. The five cases with tumors located on the anterior/anterolateral bladder wall received the extraperitoneal approach. The six cases with tumors located around the bladder dome or over the posterior bladder wall received the transperitoneal approach. Key perioperative parameters were recorded. Results: All patients underwent laparoscopic resection smoothly without requiring a conversion to a traditional open procedure, and no patient displayed perioperative complications. Pathology showed benign non-urothelial bladder tumors with normal margins in all eleven patients, including five leiomyoma cases, three pheochromocytoma cases, two paraganglioma cases and one inflammatory fibrous histiocytoma case. Follow-up cystoscopy and imaging studies in all eleven patients (mean follow-up period 32 months) revealed neither residual nor local recurrence. Conclusions: LPC is safe and feasible in select patients with benign non-urothelial bladder tumors and yields satisfactory oncological and functional results. Extraperitoneal LPC should be preferred for lesions located on the anterior/anterolateral bladder wall, while transperitoneal LPC should be preferred for lesions around the bladder dome or over the posterior bladder wall.

show abstract

Laparoscopic partial cystectomy for treatment of adenocarcinoma of the urachus

Cited by 32 publications

References 11 publications

Robotic Partial Cystectomy for Bladder Cancer: A Single-Institutional Pilot Study

Robotic Partial Cystectomy for Bladder Cancer: A Single-Institutional Pilot Study

The role of robotic partial cystectomy in a patient with metastatic primary adenocarcinoma of the bladder

Extraperitoneal and Transperitoneal Laparoscopic Partial Cystectomy for Benign Non-Urothelial Bladder Tumors: An Initial Experience

Contact Info

Product

Resources

About